In this study, we conducted a pan-cancer analysis of sex hormone nuclear receptors, including the AR, estrogen receptors (ER), and progesterone receptor (PR), with extended analysis of AR given our previous findings (11, 15). This evidence concerns the gene ESR1 and cancer.